Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Items 801–900 of 1,002
Decreased Fetal Size Is Associated With β-Cell Hyperfunction in Early Life and Failure With Age
Chakravarthy, M. V., Zhu, Y., Wice, M. B., Coleman, T., Pappan, K. L., Marshall, C. A., McDaniel, M. L., & Semenkovich, C. F. (2008) · Diabetes · doi:10.2337/db08-0404 · Cited by 25
Insulin resistance in the retina: possible implications for certain ocular diseases
Zheng, Z., & Yu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1415521 · Cited by 30
“In later stages, the insulin production is lower than normal, and hypoinsulinemia would be observed with the progressive reduced number and functional exhaustion of pancreatic b -cells (26).”
BackgroundKubrak, O. I., Jørgensen, A. F., Koyama, T., Lassen, M., Nagy, S., Hald, J., Mazzoni, G., Madsen, D., Hansen, J. B., Larsen, M. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50468-w · Cited by 29
“In both fl ies and mammals, fat-derived hormones (leptin or Unpaired-2) convey metabolic informa-tionandact viaaneuronalrelaytoregulateinsulinsecretion 24,61 .”
InfluentialLonardo, A., & Weiskirchen, R. (2025) · Biomolecules · doi:10.3390/biom15121745 · Cited by 39
“This elevation sustains near-normal glycemia despite IR, which is indicative of β -cell compensation, followed by a subsequent decline as fasting glycemia exceeds the upper normal limit of 5.5 mM ( β -cell failure) [137].”
InfluentialTran, K. C., Li, Y., Duan, H., Arora, D. K., Lim, H., & Wang, W. (2014) · ACS Chemical Biology · doi:10.1021/cb500740d · Cited by 31
Zhao, T., Ma, J., Li, L., Teng, W., Tian, Y., Ma, Y., Wang, W., Yan, W., & Jiao, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197161 · Cited by 26
“This disease is complicated and characterized by hyperglycemia and impaired insulin secretion by islet β-cells [3,4].”
BackgroundInappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic
Schulz, M. C., & Sargis, R. M. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.04.002 · Cited by 31
Zarina, Z., Wani, A. W., Rawat, M., Kaur, H., Das, S., Kaur, T., Akram, N., Faisal, Z., Jan, S. S., Oyshe, N. N., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4139 · Cited by 38
“%) comprise the large levels of carotenoids present in fresh leaves (Prentki & Nolan, 2006).”
BackgroundAnimal Models of Diabetes-Induced Neuropathic Pain
Lee-Kubli, C. A., Mixcoatl-Zecuatl, T., Jolivalt, C. G., & Calcutt, N. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_280 · Cited by 29
Jin, H., Kim, J., Lee, S., Kim, K., Go, M. J., Lee, J., Lee, H., Song, J., Jeon, B. T., Roh, G. S., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.031 · Cited by 29
“Progressive b-cell failure, which includes disruption of b-cell function and reduction of b-cell mass, is the central component of the onset and progression of T2D (Prentki and Nolan, 2006).”
BackgroundNie, J., Lilley, B. N., Pan, Y. A., Faruque, O. M., Liu, X., Zhang, W., Sanes, J. R., Han, X., & Shi, Y. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00285-13 · Cited by 27
Giannulis, I., Mondini, E., Cinti, F., Frontini, A., Murano, I., Barazzoni, R., Barbatelli, G., Accili, D., & Cinti, S. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.006 · Cited by 30
Connexin-dependent signaling in neuro-hormonal systems
Potolicchio, I., Cigliola, V., Velázquez-García, S., Klee, P., Valjevac, A., Kapić, D., Ćosović, E., Lepara, O., Hadžović-Džuvo, A., Mornjacovic, Z., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.09.022 · Cited by 27
The Role and Future of FFA1 as a Therapeutic Target
Ghislain, J. J., & Poitout, V. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_51 · Cited by 31
“Etiological studies of T2D progression suggest that chronic hyperglycemia and hyperlipidemia aggravate β-cell dysfunction, a phenomenon known as glucolipotoxicity (Poitout and Robertson 2008; Prentki and Nolan 2006).”
BackgroundVeluthakal, R., Chepurny, O. G., Leech, C. A., Schwede, F., Holz, G. G., & Thurmond, D. C. (2018) · Diabetes · doi:10.2337/db17-1174 · Cited by 26
Mitochondria Associated Membranes (MAMs): Emerging Drug Targets for Diabetes
Sasi, U. S. S., Ganapathy, S., Palayyan, S. R., & Gopalan, R. K. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190212121248 · Cited by 29
Ning, F. C., Jensen, N., Mi, J., Lindström, W., Bălan, M., Muhl, L., Eriksson, U., Nilsson, I., & Nyqvist, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-57599-2 · Cited by 28
Kidney in Diabetes: from Organ Damage Target to Therapeutic Target
Salvatore, T., Carbonara, O., Cozzolino, D., Torella, R., Nasti, R., Lascar, N., & Sasso, F. C. (2011) · Current Drug Metabolism · doi:10.2174/138920011796504509 · Cited by 30
The Relationship between Betatrophin Levels in Blood and T2DM: A Systematic Review and Meta-Analysis
Yue, S., Wu, J., Zhang, J., Liu, L., & Chen, L. (2016) · Disease Markers · doi:10.1155/2016/9391837 · Cited by 27
Garcés‐Rimón, M., González, C., Vera, G., Uranga, J. A., López‐Fandiño, R., López‐Miranda, V., & Miguel, M. (2018) · Nutrients · doi:10.3390/nu10040441 · Cited by 27
“Therefore, hyperglycaemia, once established, promotes a further series of mechanisms that eventually cause severe β cell failure and DM2 [28,29].”
BackgroundInfluentialLee, D., Shin, Y., Jang, J., Park, Y.-H., Ahn, J., Jeong, S., Shin, S. S., & Yoon, M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112646 · Cited by 27
S1P Signaling Pathways in Pathogenesis of Type 2 Diabetes
He, Q., Bo, J., Shen, R., Li, Y., Zhang, Y., Zhang, J., Yang, J., & Liu, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/1341750 · Cited by 26
Long Non-Coding RNAs (lncRNAs) in Cardiovascular Disease Complication of Type 2 Diabetes
Ismail, N., Abdullah, N., Murad, N. A. A., Jamal, R., & Sulaiman, S. A. (2021) · Diagnostics · doi:10.3390/diagnostics11010145 · Cited by 30
“The progressive loss of β-cells is common in T2D disease development [78].”
BackgroundMaheshkumar, K., Vijayakumar, V., Geethanjali, S., Poonguzhali, S., Padmavathi, R., Mahadevan, S., & Silambanan, S. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210405104335 · Cited by 33
Lazard, D., Vardi, P., & Bloch, K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2294 · Cited by 24
Delta Cell Hyperplasia in Adult Goto-Kakizaki (GK/MolTac) Diabetic Rats
Alán, L., Olejár, T., Cahová, M., Zelenka, J., Berková, Z., Smětáková, M., Saudek, F., Matěj, R., & Ježek, P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/385395 · Cited by 24
Exposure of mouse embryonic pancreas to metformin enhances the number of pancreatic progenitors
Gregg, B. E., Elghazi, L., Alejandro, E. U., Smith, M. R., Blandino-Rosano, M., El‐Gabri, D., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2014) · Diabetologia · doi:10.1007/s00125-014-3379-5 · Cited by 25
Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus
Gallwitz, B. (2010) · Drug Safety · doi:10.2165/11319130-000000000-00000 · Cited by 24
High Glucose Aggravates the Detrimental Effects of Pancreatic Stellate Cells on Beta-Cell Function
Zha, M., Xu, W. G., Zhai, Q., Li, F.-F., Chen, B., & Sun, Z. (2014) · International Journal of Endocrinology · doi:10.1155/2014/165612 · Cited by 25
Wahab, N. A. A., Abdullah, N., & Aminudin, N. (2014) · BioMed Research International · doi:10.1155/2014/131607 · Cited by 25
Kakimoto, T., Kimata, H., Iwasaki, S., Fukunari, A., & Utsumi, H. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0456 · Cited by 27
Roche, E., Ramírez-Tortosa, C. L., Arribas, M. I., Ochoa, J. J., Sirvent-Belando, J. E., Battino, M. A., Ramírez-Tortosa, M. C., González-Alonso, A., Pérez-López, M. P., & Quiles, J. L. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt157 · Cited by 24
High-content screening identifies a role for Na + channels in insulin production
Szabat, M., Modi, H., Ramracheya, R. D., Girbinger, V., Chan, F., Lee, J. T. C., Piske, M., Kamal, S., Yang, Y. H. C., Welling, A., et al. (2015) · Royal Society Open Science · doi:10.1098/rsos.150306 · Cited by 29
Pacifici, F., Della‐Morte, D., Capuani, B., Pastore, D., Bellia, A., Sbraccia, P., Daniele, N. D., Lauro, R., & Lauro, D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7427 · Cited by 27
SREBP1c-PAX4 Axis Mediates Pancreatic β-Cell Compensatory Responses Upon Metabolic Stress
Lee, G., Jang, H., Kim, Y. Y., Choe, S. S., Kong, J., Hwang, I., Park, J., Im, S., & Kim, J. B. (2018) · Diabetes · doi:10.2337/db18-0556 · Cited by 32
Karunakaran, U., Elumalai, S., Moon, J. S., & Won, K. C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.004 · Cited by 27
Yousf, S., Sardesai, D. M., Mathew, A. B., Khandelwal, R., Acharya, J. D., Sharma, S., & Chugh, J. (2019) · Metabolomics · doi:10.1007/s11306-019-1516-3 · Cited by 27
Mammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes
Liang, H., Nie, J., Skike, C. E. V., Valentine, J. M., & Orr, M. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_10 · Cited by 27
Dhounchak, S., Popp, S. K., Brown, D. J., Laybutt, D. R., Biden, T. J., Bornstein, S. R., Parish, C. R., & Simeonovic, C. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252607 · Cited by 27
“Type 2 diabetes (T2D) is a metabolic syndrome disease in which obesity, insulin resistance, hyperglycemia, dyslipidemia and chronic low-grade inflammation of pancreatic islets contribute directly or indirectly to beta cell failure [1, 2].”
BackgroundRole of the transcriptional factor C/EBPβ in free fatty acid-elicited β-cell failure
Plaisance, V., Perret, V., Favre, D., Abderrahmani, A., Yang, J.-Y., Widmann, C., & Regazzi, R. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.005 · Cited by 27
Xu, M., Sun, B., Li, D., Mao, R., Li, H., Li, Y., & Wang, J. (2017) · Nutrients · doi:10.3390/nu9101061 · Cited by 24
“An important characteristic often associated with obesity and physical inactivity, insulin resistance precedes the development of hyperglycemia in subjects that eventually develop T2DM [3,4].”
BackgroundInfluentialLipotoxicity, β Cell Dysfunction, and Gestational Diabetes
Nolan, C. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.020 · Cited by 23
Recent advances in photopharmacology: Harnessing visible light‐activated azobenzene photoswitches
Feng, Y., Zhang, K., Gao, X., Yang, W., Wan, J., Fu, H., Guo, H., & Li, Z. (2025) · Responsive materials · doi:10.1002/rpm.20250003 · Cited by 26
CD36 initiated signaling mediates ceramide-induced TXNIP expression in pancreatic beta-cells
Karunakaran, U., Moon, J. S., Lee, H. W., & Won, K. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.009 · Cited by 27
“Impaired insulin secretion coupled to T2D is believed to be caused by several abnormalities which include mitochondrial dysfunction, oxidative stress, ER stress, hyperglycemia (glucotoxicity), dyslipidemia (lipotoxicity), and the combination of both (glucolipotoxicity) [2-8].”
BackgroundChoi, D., Cai, E. P., Schroer, S. A., Wang, L., & Woo, M. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.207 · Cited by 26
Córdoba‐Chacón, J., Gahete, M. D., Pokala, N., Geldermann, D., Alba, M., Salvatori, R., Luque, R. M., & Kineman, R. D. (2014) · Endocrinology · doi:10.1210/en.2013-1825 · Cited by 25
AKT1 Regulates Endoplasmic Reticulum Stress and Mediates the Adaptive Response of Pancreatic β Cells
Peng, Z., Aggarwal, R., Zeng, N., He, L., Stiles, E. X., Debebe, A., Chen, J., Chen, C.-Y., & Stiles, B. L. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00031-20 · Cited by 23
Han, X., Chen, X., Wang, X., Gong, M., Lu, M., Yu, Z. H., Xu, B., & Yuan, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6666323 · Cited by 26
“-e ideal model should have the above characteristics [20, 21].”
BackgroundIs Type 2 Diabetes a Primary Mitochondrial Disorder?
Weksler‐Zangen, S. (2022) · Cells · doi:10.3390/cells11101617 · Cited by 24
Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2023) · Biology · doi:10.3390/biology12050726 · Cited by 37
Li, F.-F., Chen, B.-J., Li, W., Li, L., Zha, M., Zhou, S., Bachem, M. G., & Sun, Z.-L. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6924593 · Cited by 24
Terapia celular no diabetes mellitus
Voltarelli, J. C., Couri, C. E. B., Oliveira, M. C., Moraes, D. A., Stracieri, A. B. P. L., Pieroni, F., Navarro, G., Madeira, M. I. A., & Simões, B. P. (2009) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842009005000036 · Cited by 27
Omori, K., Nakamura, A., Miyoshi, H., Yamauchi, Y., Kawata, S., Takahashi, K., Kitao, N., Nomoto, H., Kameda, H., Cho, K. Y., et al. (2021) · Diabetes · doi:10.2337/db20-0881 · Cited by 30
Fetuin‐A excess expression amplifies lipid induced apoptosis and β‐cell damage
Mukhuty, A., Fouzder, C., & Kundu, R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30499 · Cited by 23
JNK3 Is Required for the Cytoprotective Effect of Exendin 4
Ezanno, H., Pawlowski, V., Abdelli, S., Boutry, R., Gmyr, V., Kerr-Conte, J. A., Bonny, C., Pattou, F. N., & Abderrahmani, A. (2014) · Journal of Diabetes Research · doi:10.1155/2014/814854 · Cited by 25
Spiegel, A. M., & Hawkins, M. A. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1054 · Cited by 25
Novelli, M., D’Aleo, V., Lupi, R., Paolini, M., Soleti, A., Marchetti, P., & Masiello, P. (2007) · Pancreas · doi:10.1097/mpa.0b013e318150e4f2 · Cited by 24
The required beta cell research for improving treatment of type 2 diabetes
Thorens, B. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12096 · Cited by 26
Malcomson, F. C., & Mathers, J. C. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_13 · Cited by 26
Fischer, A. W., Albers, K., Schlein, C., Sass, F., Krott, L. M., Schmale, H., Gordts, P. L. S. M., Scheja, L., & Heeren, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.03.010 · Cited by 25
Dual effects of obesity on satellite cells and muscle regeneration
Geiger, A. E., Daughtry, M. R., Yen, C., Kirkpatrick, L. T., Shi, H., & Gerrard, D. E. (2020) · Physiological Reports · doi:10.14814/phy2.14511 · Cited by 24
“…hyperinsulinemia with a high level of circulating insulin, a well-known myoblast proliferation and differentiation enhancer (Allen & Rankin, 1990; Brown et al., 2016; Prentki & Nolan, 2006), which may boost SC function and thus compensate HFD-caused SC harm in vivo, at least in a temporary manner.”
BackgroundAl‐Mass, A., Poursharifi, P., Peyot, M., Lussier, R., Chénier, I., Leung, Y. H., Ghosh, A., Oppong, A. K., Possik, E., Mugabo, Y., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101609 · Cited by 27
Self-citationCNV Analysis Associates AKNAD1 with Type-2 Diabetes in Jordan Subpopulations
Dajani, R. B., Li, J., Wei, Z., Glessner, J., Chang, X., Cardinale, C. J., Pellegrino, R., Wang, T., Hakooz, N., Khader, Y. S., et al. (2015) · Scientific Reports · doi:10.1038/srep13391 · Cited by 27
Role of Transcription Factor Modifications in the Pathogenesis of Insulin Resistance
Kim, M., Bae, J.-S., Kim, T. H., Park, J.-M., & Ahn, Y. (2011) · Experimental Diabetes Research · doi:10.1155/2012/716425 · Cited by 25
Lam, A. K., Silva, P. N., Altamentova, S. M., & Rocheleau, J. V. (2012) · Integrative Biology · doi:10.1039/c2ib20075a · Cited by 28
High-fat diet effects on metabolic responses to chronic stress
Nemati, M., Zardooz, H., Rostamkhani, F., Abadi, A., & Foroughi, F. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1295083 · Cited by 23
“It is noteworthy that high-fat feeding at first increase pancreatic islets’ insulin secretion and the islets’ diameter, to cope with the insulin resistance but eventually can lead to beta cells disruption and finally insulin secretion decrement (Cerf, 2013; Prentki & Nolan, 2006).”
BackgroundThe Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
McClements, L., Annett, S., Yakkundi, A., & Robson, T. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150519115729 · Cited by 23
Chakraborty, S., Bhattacharyya, R., & Banerjee, D. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.11.004 · Cited by 25
Lamontagne, J., Al‐Mass, A., Nolan, C. J., Corkey, B. E., Madiraju, S. R. M., Joly, E. C., & Prentki, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.808105 · Cited by 25
Self-citationHigh-Throughput Approaches onto Uncover (Epi)Genomic Architecture of Type 2 Diabetes
Dziewulska, A., Dobosz, A. M., & Dobrzyń, A. (2018) · Genes · doi:10.3390/genes9080374 · Cited by 26
Faraj, M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190124 · Cited by 25
Cao, Z., Yao, F., Lang, Y., & Feng, X. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1247-4978 · Cited by 23
Broussard, J. L., Nelson, M. D., Kolka, C. M., Bediako, I. A., Paszkiewicz, R. L., Smith, L., Szczepaniak, E. W., Stefanovski, D., Szczepaniak, L. S., & Bergman, R. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3767-5 · Cited by 25
Park, S.-Y., & Bell, G. I. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1087209 · Cited by 22
Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus
Sou, Y. L., Chilian, W. M., Ratnam, W., Zain, S. M., Kadir, S. Z. S. A., Pan, Y., & Pung, Y. F. (2024) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbae021 · Cited by 26
Lamantia, V., Bissonnette, S., Beaudry, M., Cyr, Y., Rosiers, C. D., Baass, A. W., & Faraj, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-73672-6 · Cited by 26
Preserved Proinsulin Secretion in Long-Standing Type 1 Diabetes
Steenkamp, D., Cacicedo, J. M., Sahin-Efe, A., Sullivan, C. A. W., & Sternthal, E. (2017) · Endocrine Practice · doi:10.4158/ep-2017-0009 · Cited by 22
Epigenetics in β-cell adaptation and type 2 diabetes
Kim, H., & Kulkarni, R. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.10.008 · Cited by 26
Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes
Mir-Coll, J., Moede, T., Paschen, M., Neelakandhan, A., Valladolid‐Acebes, I., Leibiger, B., Biernath, A., Ämmälä, C., Leibiger, I. B., Yesildag, B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041813 · Cited by 26
“7 mM glucose compared to 8 mM and 11 mM glucose, which suggests that under these conditions β-cells were not able to keep up with the increased insulin secretory demand and reached the “breaking point” known as β-cell failure [2].”
Solanum anguivi Lam. Fruits: Their Potential Effects on Type 2 Diabetes Mellitus
Nakitto, A. M. S., Muyonga, J. H., Byaruhanga, Y. B., & Wagner, A. E. (2021) · Molecules · doi:10.3390/molecules26072044 · Cited by 25
Schaschkow, A., Pang, L., Vandenbempt, V., Elvira, B., Litwak, S. A., Vekeriotaite, B., Maillard, É., Vermeersch, M., de Paula, F. M. M., Pinget, M., et al. (2021) · Diabetes · doi:10.2337/db20-1222 · Cited by 25
Agrawal, A., Narayan, G., Gogoi, R., & Thummer, R. P. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_653 · Cited by 24
Shang, J., Zhu, C., Wang, M., Li, Q., Feng, W. M., Wu, Y., Wu, W., Graziano, M. P., & Chintala, M. S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.04.008 · Cited by 23
Grow Moringa (Moringa oleifera), the miracle tree on the earth
Rajbhar, Y. P., Rajbhar, G., Rawat, P., Shukla, S., & Kumar, M. (2018) · Horticulture International Journal · doi:10.15406/hij.2018.02.00047 · Cited by 23
Lv, W., Zhang, J., Jiao, A., Wang, B., Chen, B., & Lin, J. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0686 · Cited by 21
Shin, Y., Lee, D., Ahn, J., Lee, M., Shin, S. S., & Yoon, M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113360 · Cited by 22
Selective beta-cell toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin on isolated pancreatic islets
Novelli, M., Beffy, P., Masini, M., Vantaggiato, C., Martino, L., Marselli, L., Marchetti, P., & Tata, V. D. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.129103 · Cited by 23
Inhibition of BACE2 counteracts hIAPP‐induced insulin secretory defects in pancreatic β‐cells
Alcarraz‐Vizán, G., Casini, P., Cadavez, L., Visa, M., Montané, J., Servitja, J., & Novials, A. (2014) · The FASEB Journal · doi:10.1096/fj.14-255489 · Cited by 21
“It is well known that the progressive loss of b-cell mass and function are key features of the manifestation of the underlying disease (1).”
BackgroundAccili, D., Åhrén, B., Boîtard, C., Cerasi, E., Henquin, J. C., & Seino, S. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01296.x · Cited by 23
Aguerd, O., Elhrech, H., Fessikh, M. E., Goh, K. W., Omari, N. E., Aanniz, T., & Bouyahya, A. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106705 · Cited by 24
Current Therapies for the Medical Management of Diabetes
Inzucchi, S. E., & Majumdar, S. K. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001332 · Cited by 22
Gan, Q., Lin, C.-Y., Lu, C., Chang, Y., Che, Q., Zhang, G., Zhu, T., Gu, Q., Wu, Z., Li, M., et al. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00535 · Cited by 20
Li, Z., Pan, X., & Cai, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.890901 · Cited by 25
Khater, S. I., El-Emam, M. M. A., Abdellatif, H., Mostafa, M., Khamis, T., Soliman, R. H. M., Ahmed, H. S., Ali, S. K., Selim, H. M. R. M., Alqahtani, L. S., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122546 · Cited by 21
Broussard, J. L., Kolka, C. M., Castro, A. V., Bediako, I. A., Paszkiewicz, R. L., Szczepaniak, E. W., Szczepaniak, L. S., Knutson, K. L., Kim, S. P., & Bergman, R. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3721-6 · Cited by 20
Sato, K., Nakamura, A., Shirakawa, J., Muraoka, T., Togashi, Y., Shinoda, K., Orime, K., Kubota, N., Kadowaki, T., & Terauchi, Y. (2012) · Endocrinology · doi:10.1210/en.2011-1712 · Cited by 20
Delghingaro‐Augusto, V., Madad, L., Chandra, A., Simeonovic, C. J., Dahlstrom, J. E., & Nolan, C. J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.01.024 · Cited by 22
Loss of β-arrestin2 mediates pancreatic-islet dysfunction in mice
Zhang, M., Zhu, Y., Mu, K., Li, L., Lu, J., Zhao, J., Huang, X., Wang, C., & Jia, W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.079 · Cited by 20
Selective mtDNA mutation accumulation results in β-cell apoptosis and diabetes development
Bensch, K. G., Mott, J. L., Chang, S.-W., Hansen, P. A., Moxley, M. A., Chambers, K. T., Graaf, W. F.-D., Zassenhaus, H. P., & Corbett, J. A. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90839.2008 · Cited by 25
Tuo, Y., Feng, D., Wang, D., Sun, J. H., Li, S., & Chen, C. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05691.x · Cited by 23
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.